Terms: = Breast cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Treatment
134 results:
1. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
[TBL] [Abstract] [Full Text] [Related]
2. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative breast cancer Cells.
Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
[TBL] [Abstract] [Full Text] [Related]
3. RAS‑stimulated release of exosomal
Kim O; Tran PT; Gal M; Lee SJ; Na SH; Hwangbo C; Lee JH
Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37503759
[TBL] [Abstract] [Full Text] [Related]
4. Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines.
Tawfeeq N; Lazarte JMS; Jin Y; Gregory MD; Lamango NS
Oncotarget; 2023 Mar; 14():243-257. PubMed ID: 36961909
[TBL] [Abstract] [Full Text] [Related]
5. Role of a Mixture of Polyphenol Compounds Released after Blueberry Fermentation in Chemoprevention of Mammary Carcinoma: In Vivo Involvement of miR-145.
Mallet JF; Shahbazi R; Alsadi N; Saleem A; Sobiesiak A; Arnason JT; Matar C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835085
[TBL] [Abstract] [Full Text] [Related]
6. Historical redlining and breast cancer treatment and survival among older women in the United States.
Bikomeye JC; Zhou Y; McGinley EL; Canales B; Yen TWF; Tarima S; Ponce SB; Beyer KMM
J Natl Cancer Inst; 2023 Jun; 115(6):652-661. PubMed ID: 36794919
[TBL] [Abstract] [Full Text] [Related]
7. Expression and Function of StAR in cancerous and Non-cancerous Human and Mouse breast Tissues: New Insights into Diagnosis and treatment of Hormone-Sensitive breast cancer.
Manna PR; Ramachandran S; Pradeepkiran JA; Molehin D; Castro-Piedras I; Pruitt K; Ganapathy V; Reddy PH
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614200
[TBL] [Abstract] [Full Text] [Related]
8. Ras-transfected human mammary tumour cells are resistant to photodynamic therapy by mechanisms related to cell adhesion.
Rodriguez L; Di Venosa G; Rivas MA; Juarranz A; Sanz-Rodriguez F; Casas A
Life Sci; 2023 Feb; 314():121287. PubMed ID: 36526044
[TBL] [Abstract] [Full Text] [Related]
9. Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.
Sivakumar S; Jin DX; Tukachinsky H; Murugesan K; McGregor K; Danziger N; Pavlick D; Gjoerup O; Ross JS; Harmon R; Chung J; Decker B; Dennis L; Frampton GM; Molinero L; Oesterreich S; Venstrom JM; Oxnard GR; Hegde PS; Sokol ES
Nat Commun; 2022 Dec; 13(1):7495. PubMed ID: 36470901
[TBL] [Abstract] [Full Text] [Related]
10. Induction of apoptosis and suppression of Ras gene expression in MCF human breast cancer cells.
Saremi S; Kolahi M; Tabandeh MR; Hashemitabar M
J Cancer Res Ther; 2022; 18(4):1052-1060. PubMed ID: 36149161
[TBL] [Abstract] [Full Text] [Related]
11. Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways.
Wang F; Yuan C; Liu B; Yang YF; Wu HZ
J Transl Med; 2022 Jul; 20(1):310. PubMed ID: 35794555
[TBL] [Abstract] [Full Text] [Related]
12. Differential proteome and functional analysis of NSCLC cell lines in response to Tualang honey treatment.
Amran N; Abdul-Rahman PS
J Ethnopharmacol; 2022 Jul; 293():115264. PubMed ID: 35398242
[TBL] [Abstract] [Full Text] [Related]
13. Primary breast sarcoma: A case series.
Ahuja M; Mallya V; Mandal S; Tomar R; Aggarwal R; Khurana N; Lal P
Indian J Pathol Microbiol; 2022; 65(1):152-156. PubMed ID: 35074983
[TBL] [Abstract] [Full Text] [Related]
14. TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
Grote I; Bartels S; Kandt L; Bollmann L; Christgen H; Gronewold M; Raap M; Lehmann U; Gluz O; Nitz U; Kuemmel S; Zu Eulenburg C; Braun M; Aktas B; Grischke EM; Schumacher C; Luedtke-Heckenkamp K; Kates R; Wuerstlein R; Graeser M; Harbeck N; Christgen M; Kreipe H
Cancer Med; 2021 Dec; 10(23):8581-8594. PubMed ID: 34779146
[TBL] [Abstract] [Full Text] [Related]
15. hras is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
Bièche I; Coussy F; El-Botty R; Vacher S; Château-Joubert S; Dahmani A; Montaudon E; Reyes C; Gentien D; Reyal F; Ricci F; Nicolas A; Marchio C; Vincent-Salomon A; Laé M; Marangoni E
J Hematol Oncol; 2021 Sep; 14(1):143. PubMed ID: 34496925
[TBL] [Abstract] [Full Text] [Related]
16. Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers.
Cole KM; Clemons M; Alzahrani M; Larocque G; MacDonald F; Vandermeer L; Hutton B; Piper A; Pond G; McGee S
Breast Cancer Res Treat; 2021 Jul; 188(2):343-350. PubMed ID: 34159473
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
18. Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.
Groeneveldt C; Kinderman P; van den Wollenberg DJM; van den Oever RL; Middelburg J; Mustafa DAM; Hoeben RC; van der Burg SH; van Hall T; van Montfoort N
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33082167
[TBL] [Abstract] [Full Text] [Related]
19. IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas.
Wang Q; Zhang Y; Zhu J; Zheng H; Chen S; Chen L; Yang HS
Signal Transduct Target Ther; 2020 Aug; 5(1):153. PubMed ID: 32843616
[TBL] [Abstract] [Full Text] [Related]
20. MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant breast cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway.
Wu HT; Liu YE; Hsu KW; Wang YF; Chan YC; Chen Y; Chen DR
Am J Chin Med; 2020; 48(5):1221-1241. PubMed ID: 32668964
[TBL] [Abstract] [Full Text] [Related]
[Next]
